20,21-Dinoribogamine-18-carboxylicacid, 3,4-didehydro-2-ethyl-, methyl ester, (2a,5b,6a,18b)- (9CI) (26033-14-7)

Identification
Name:	20,21-Dinoribogamine-18-carboxylicacid, 3,4-didehydro-2-ethyl-, methyl ester, (2a,5b,6a,18b)- (9CI)
Synonyms:	6,9-Methano-5H-pyrido[1',2':1,2]azepino[4,5-b]indole,20,21-dinoribogamine-18-carboxylic acid deriv.; (+)-Allocatharanthine;Allocatharanthin; Allocatharanthine
CAS:	26033-14-7
Molecular Formula:	C21H24 N2 O2
Molecular Structure:
Properties
Safety Data

Other Product

Ibogamine-18-carboxylicacid, 3,4-didehydro-, methyl ester, monohydrochloride, (2a,5b,6a,18b)-
Ibogamine-18-methanol,3,4-didehydro-, (2a,5b,6a,18b)- (9CI)
Ibogamine-18-carboxylicacid, 4-hydroxy-, g-lactone, (2a,4a,5b,6a,18b)- (9CI)
Ibogamine, (2a,5b,6a,18b)- (9CI)
Aspidospermidine-3-carboxylicacid, 2,3-didehydro-21-hydroxy-20-oxo-, methyl ester, (5a,12R,19a)- (9CI)
5-Thia-1-azabicyclo[4.2.0]octane-2-carboxylicacid, 3-methylene-8-oxo-7-[(phenylacetyl)amino]-, (4-nitrophenyl)methyl ester,5-oxide, [2R-(2a,5b,6a,7b)]- (9CI)
21-Phorbinecarboxylicacid,3-[(1E)-2-carboxyethenyl]-3,4-didehydro-9-ethenyl-14-ethyl-4,8,13,18-tetramethyl-20-oxo-,21-methyl ester (9CI)
Aspidofractinine-3-carboxylicacid, 6,7-epoxy-20-hydroxy-, methyl ester, (2a,3b,5a,6a,7a,20S)- (9CI)
Yohimban-16-carboxylicacid,18-[[(2E)-3-(4-hydroxy-3-methoxyphenyl)-1-oxo-2-propenyl]oxy]-11,17-dimethoxy-,methyl ester, (3b,16b,17a,18b,20a)- (9CI)
2H-Indazole-5-carboxylicacid, 2-benzoyl-3-(benzoyloxy)-4,5,6,7-tetrahydro-6-hydroxy-6-methyl-4-phenyl-,ethyl ester, (4a,5b,6a)- (9CI)
Yohimban-16-carboxylicacid, 11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester,4-oxide, (3b,16b,17a,18b,20a)- (9CI)
Yohimban-16-carboxylicacid,1-[2-(diethylamino)ethyl]-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-,methyl ester, (3b,16b,17a,18b,20a)-
Benzenediazonium,4-[2-[[(1b,3b,5b,11a,14b)-20,23-epoxy-1,5,11,14,19-tetrahydroxy-23-oxo-24-norchol-20(22)-en-3-yl]oxy]hexahydro-6-hydroxy-7-methyl-1,4-oxazepin-4-yl]-,[2R-(2a,6a,7b)]- (9CI)
3-Phorbinepropanoicacid,3,4-didehydro-9,14-diethyl-21-(methoxycarbonyl)-4,8,13,18-tetramethyl-20-oxo-,methyl ester (9CI)
2H-Indazole-5-carboxylicacid, 4,5,6,7-tetrahydro-3,6-dihydroxy-6-methyl-4-[4-(phenylmethoxy)phenyl]-,ethyl ester, (4a,5b,6a)- (9CI)
2H-Indazole-5-carboxylicacid,3-(3-ethoxy-3-oxopropoxy)-4,5,6,7-tetrahydro-6-hydroxy-6-methyl-4-phenyl-,ethyl ester, (4a,5b,6a)- (9CI)
2H-Indazole-5-carboxylicacid, 4,5,6,7-tetrahydro-3,6-dihydroxy-6-methyl-4-phenyl-, ethyl ester, (4a,5b,6a)- (9CI)
2H-Indazole-5-carboxylicacid,4-[3-ethoxy-4-(phenylmethoxy)phenyl]-4,5,6,7-tetrahydro-3,6-dihydroxy-6-methyl-,ethyl ester, (4a,5b,6a)- (9CI)
1-Azabicyclo[3.2.0]heptane-2-carboxylicacid, 6-(1-hydroxyethyl)-3,7-dioxo-, (4-nitrophenyl)methyl ester, [2S-[2a,5b,6b(S*)]]- (9CI)
1H-Indazole-5-carboxylicacid,4,5,6,7-tetrahydro-6-hydroxy-6-methyl-4-phenyl-3-(phenylmethoxy)-1-(phenylmethyl)-,ethyl ester, (4a,5b,6a)- (9CI)